The chemistry at the heart of the study is cross-coupling, one of the most widely used strategies in modern synthetic chemistry. In a cross-coupling reaction, two molecular building blocks are joined by a newly formed chemical bond with the help of a metal catalyst. Because most drugs are not harvested from nature but assembled through multistep chemical processes, this bond-forming strategy underpins a huge share of the pharmaceutical industry’s synthetic toolkit. A catalyst, in the strict sense of the term, is a substance that enables or accelerates a chemical reaction without being consumed itself. In practice, many catalysts consist of single metal atoms connected to organic molecules called ligands, which influence how the metal behaves and can be deliberately designed to fine-tune its catalytic properties.

For decades, the metal of choice for many important cross-coupling reactions has been palladium. The significance of palladium-catalyzed cross-coupling in organic synthesis was recognized with the 2010 Nobel Prize in Chemistry, awarded to Richard Heck, Ei-ichi Negishi, and Akira Suzuki. These reactions have become influential tools for constructing complex molecules, including pharmaceuticals, and palladium catalysts remain highly efficient. The drawback is equally well known: palladium is a noble metal, meaning it is scarce and expensive. Any chemistry that depends on loading large quantities of it into reaction vessels carries a cost, both financial and environmental, that grows uncomfortable at industrial scale.

Roughly a decade ago, researchers demonstrated an intriguing alternative. By combining a nickel catalyst with a second catalyst capable of converting visible light into chemical energy, they could carry out couplings that would otherwise rely on palladium. Nickel is far more abundant and far cheaper than palladium, so the approach promised cheaper and more sustainable reactions. But there was a catch, and it was a serious one. Nickel catalysts of that era were less efficient than their palladium counterparts and did not enable the same breadth of reactions. The promise of light-driven nickel catalysis came wrapped in practical limitations that kept it out of most working chemists’ hands.

The Pieber group has spent years probing those limitations. In their own words, the laboratory tries to understand why contemporary nickel catalysis systems have limitations, and, based on that understanding, designs, makes, and studies alternative candidates and methods. An important step came in 2020, when the researchers showed that nickel catalysts can be destroyed when challenging building blocks are used, and that this destruction can be avoided by carefully controlling the reaction conditions. The demonstration proved that the weaknesses of nickel catalysis were not insurmountable. It was, however, still far from an efficient method, as Pieber himself acknowledges. The reactions ran very slowly and required high amounts of nickel catalyst to deliver their products.

The new study grew out of that accumulating understanding. Aleksander Bena, a PhD student in the group, took the growing mechanistic picture and used it to design possible structures for more efficient and robust nickel catalysts that could be directly activated with visible light, then tested his ideas experimentally in the laboratory. That iterative process of proposing a structure, running the reaction, and learning from each result ultimately led the team to a new ligand, the organic framework wrapped around the nickel atom, that helps the metal overcome many of the remaining limitations of light-driven catalysis. The result is a catalyst system that is broadly applicable and requires substantially less nickel than earlier light-driven approaches.

The technical heart of the breakthrough is that tailor-made ligand, which boosts the catalytic activity of the nickel atom once the system is initiated with visible light. With that boost in place, the catalyst can form bonds between carbon atoms and a strikingly wide range of partner atoms, including nitrogen, oxygen, sulfur, and phosphorus, fusing two molecules into a larger and more complex structure in each case. That breadth matters enormously in practice. Drug molecules and other fine chemicals rarely contain just one kind of heteroatom linkage, so a catalyst that handles carbon-nitrogen, carbon-oxygen, carbon-sulfur, and carbon-phosphorus bonds alike can serve many different synthetic campaigns without bespoke optimization for each one.

The numbers behind the new system are what make it stand out. The researchers reduced the catalyst loading to 100 parts per million, equivalent to 0.01 mol percent. Put plainly, in such an experiment a single molecule of the nickel catalyst produces up to 10,000 molecules of product. Catalyst loadings that low have, until now, typically been achieved only with catalysts based on palladium. Being able to reach that performance threshold with nickel is, according to the team, genuinely exciting, because it suggests that the abundant metal can, with the right ligand design, match one of the key performance benchmarks that has kept palladium entrenched in industrial practice.

To demonstrate that the system was not a one-reaction curiosity, a small task force formed within the Pieber group, consisting of Trisha Banik, Christos Giannoudis, Florian Ortis, Haralds Baunis, and Gayathri Palissery, set out to study the general applicability of the new catalyst. The team showcased its versatility by making more than 150 distinct products. The range stretched from simple building blocks to complex molecules and included derivatives of established drugs, among them fluoxetine, one of the most commonly prescribed antidepressants in the world. Demonstrating the chemistry on drug derivatives is a meaningful signal for pharmaceutical synthesis, since it suggests the method can tolerate the dense, functionalized molecular environments that real medicinal chemistry demands.

The study, which also involved Daniel Bím of the University of Chemistry and Technology in Prague, ultimately makes a broader argument than any single reaction does. It shows that understanding the fundamental reactivity of nickel-based molecules, down to the level of how catalysts fail and how ligands can protect and empower them, can turn an abundant, inexpensive metal into a catalyst with performance once reserved for precious metals. The combination of low catalyst loading and high generality across many building blocks could make the approach particularly interesting for pharmaceutical and fine-chemical synthesis, where every gram of metal saved and every step simplified translates directly into lower costs and cleaner processes. For an industry under pressure to green its supply chains, a blue lamp and a well-designed ligand may prove to be a quietly powerful combination.

Subject of Research: Light-driven nickel-catalyzed cross-coupling reactions using a tailored ligand to achieve low catalyst loadings

Article Title: Efficient catalysis with less metal

Article References: Efficient catalysis with less metal. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: nickel catalysis, cross-coupling, visible light activation, ligand design, palladium alternatives, Nature Catalysis, pharmaceutical synthesis, sustainable chemistry, catalyst loading, heteroatom bonds, ISTA, fluoxetine